Sentences with phrase «pimobendan resulted»

The EPIC Study showed that administration of pimobendan resulted in a 15 ‑ month delay in onset of clinical signs of CHF, cardiac ‑ related death, or euthanasia compared with dogs receiving placebo.
The EPIC Study showed that administration of pimobendan resulted in a 15 ‑ month delay in time to primary endpoint compared with dogs receiving placebo.

Not exact matches

These encouraging results led us to believe that pimobendan could be effective in preclinical mitral valve disease and that the investigation of this through the EPIC Study was useful and worthwhile.
Other clinical studies conducted to evaluate the effects of pimobendan have shown positive results, which have subsequently led to the appropriate treatment of dogs worldwide.
As a balanced vasodilator, pimobendan dilates both veins and arteries resulting in a reduction in preload and afterload.
Pimobendan is proven to decrease preload and afterload, and this, in combination with pimobendan's inotropic properties, may result in a reduction in cardiac size and filling pressures in dogs with significant cardiac remodelling secondarPimobendan is proven to decrease preload and afterload, and this, in combination with pimobendan's inotropic properties, may result in a reduction in cardiac size and filling pressures in dogs with significant cardiac remodelling secondarpimobendan's inotropic properties, may result in a reduction in cardiac size and filling pressures in dogs with significant cardiac remodelling secondary to MMVD.
Recent results from the EPIC Study, however, show that pimobendan, when administered to dogs in stage B2 — before clinical signs of heart failure appear — succeeded in delaying the onset of CHF.
Groundbreaking results of the EPIC (Evaluation of Pimobendan In dogs with Cardiomegaly) Study, the largest veterinary cardiology study in history, are now published.
This license extension follows the results of a clinical trial — the so called EPIC trial — which studied the effect of pimobendan (the active ingredient in...
a b c d e f g h i j k l m n o p q r s t u v w x y z